/
Psychiatry
Postpartum Depression
12
Pipeline Programs↗
20
Active Trials↗
11
Companies Involved↗
Postpartum Depression is an emerging landscape with 12 programs across 11 companies. The most active players are Biogen.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical11
Phase 1
No programs
Phase 3
No programs
Approved
No programs
Analysis
Trial Status
72
clinical trials
Completed37 · 51%
Recruiting12 · 17%
Terminated7 · 10%
Not yet recruiting5 · 7%
Unknown status4 · 6%
Active, not recruiting3 · 4%
Other4 · 6%
Clinical Trials
Trial Activity
72 trials
Effects of Epidural Labor Analgesia With Esketamine on the Incidence of Postpartum Depression in Parturients
Recruiting·WWomen's Hospital School Of Medicine Zhejiang University·Phase 4·NCT05826327·364 enrolled
The Safety, Tolerability, and Effectiveness of Quetiapine in Postpartum Depression
Active, not recruiting·—·Phase 1·NCT04950868·22 enrolled
Page 1 of 5
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)